Results
|
|
5981.
|
Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. [electronic resource] by
- Zhang, Keqiang
- Chu, Kevin
- Wu, Xiwei
- Gao, Hanlin
- Wang, Jinhui
- Yuan, Yate-Ching
- Loera, Sofia
- Ho, Kimberley
- Wang, Yafan
- Chow, Warren
- Un, Frank
- Chu, Peiguo
- Yen, Yun
Producer: 20130415
In:
Cancer research vol. 73
Availability: No items available.
|
|
|
5982.
|
Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling. [electronic resource] by
- Zhang, Guo
- Park, Margaret A
- Mitchell, Clint
- Walker, Teneille
- Hamed, Hossein
- Studer, Elaine
- Graf, Martin
- Rahmani, Mohamed
- Gupta, Seema
- Hylemon, Philip B
- Fisher, Paul B
- Grant, Steven
- Dent, Paul
Producer: 20081020
In:
The Journal of biological chemistry vol. 283
Availability: No items available.
|
|
|
5983.
|
Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. [electronic resource] by
- Leeper, Nicholas J
- Raiesdana, Azad
- Kojima, Yoko
- Kundu, Ramendra K
- Cheng, Henry
- Maegdefessel, Lars
- Toh, Ryuji
- Ahn, G-One
- Ali, Ziad A
- Anderson, D Ryan
- Miller, Clint L
- Roberts, Scott C
- Spin, Joshua M
- de Almeida, Patricia E
- Wu, Joseph C
- Xu, Baohui
- Cheng, Karen
- Quertermous, Maximilian
- Kundu, Soumajit
- Kortekaas, Kim E
- Berzin, Erica
- Downing, Kelly P
- Dalman, Ronald L
- Tsao, Philip S
- Schadt, Eric E
- Owens, Gary K
- Quertermous, Thomas
Producer: 20130212
In:
Arteriosclerosis, thrombosis, and vascular biology vol. 33
Availability: No items available.
|
|
|
5984.
|
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers. [electronic resource] by
- Hata, A N
- Rowley, S
- Archibald, H L
- Gomez-Caraballo, M
- Siddiqui, F M
- Ji, F
- Jung, J
- Light, M
- Lee, J S
- Debussche, L
- Sidhu, S
- Sadreyev, R I
- Watters, J
- Engelman, J A
Producer: 20171204
In:
Oncogene vol. 36
Availability: No items available.
|
|
|
5985.
|
|
|
|
5986.
|
|
|
|
5987.
|
|
|
|
5988.
|
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy. [electronic resource] by
- Azmi, Asfar S
- Philip, Philip A
- Aboukameel, A
- Wang, Zhiwei
- Banerjee, Sanjeev
- Zafar, Syed F
- Goustin, Anton-Scott
- Almhanna, K
- Yang, Dajun
- Sarkar, Fazlul H
- Mohammad, Ramzi M
Producer: 20100816
In:
Current cancer drug targets vol. 10
Availability: No items available.
|
|
|
5989.
|
|
|
|
5990.
|
|
|
|
5991.
|
|
|
|
5992.
|
|
|
|
5993.
|
|
|
|
5994.
|
|
|
|
5995.
|
|
|
|
5996.
|
MDM4 is a key therapeutic target in cutaneous melanoma. [electronic resource] by
- Gembarska, Agnieszka
- Luciani, Flavie
- Fedele, Clare
- Russell, Elisabeth A
- Dewaele, Michael
- Villar, Stéphanie
- Zwolinska, Aleksandra
- Haupt, Sue
- de Lange, Job
- Yip, Dana
- Goydos, James
- Haigh, Jody J
- Haupt, Ygal
- Larue, Lionel
- Jochemsen, Aart
- Shi, Hubing
- Moriceau, Gatien
- Lo, Roger S
- Ghanem, Ghanem
- Shackleton, Mark
- Bernal, Federico
- Marine, Jean-Christophe
Producer: 20131022
In:
Nature medicine vol. 18
Availability: No items available.
|
|
|
5997.
|
|
|
|
5998.
|
|
|
|
5999.
|
|
|
|
6000.
|
|